BioCardia, Inc. (BCDA) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 15.14M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 15.14M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 15.14M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 15.14M | (m) | (m) |
| 2026-03-31 | 11.37M | (m) | (m) |
| 2025-09-30 | 10.61M | (m) | (m) |
| 2025-06-30 | 5.80M | (m) | (m) |
| 2025-03-31 | 5.18M | (m) | (m) |
| 2024-09-30 | 4.58M | (m) | (m) |
| 2024-06-30 | 2.12M | (m) | (m) |
| 2024-03-31 | 27.30M | (m) | (m) |
| 2023-09-30 | 21.62M | (m) | (m) |
| 2023-06-30 | 21.62M | (m) | (m) |
| 2023-03-31 | 20.22M | (m) | (m) |
| 2022-12-31 | 20.18M | (m) | (m) |
| 2022-09-30 | 17.84M | (m) | (m) |
| 2022-06-30 | 17.76M | (m) | (m) |
| 2022-03-31 | 17.45M | (m) | (m) |
| 2021-09-30 | 16.87M | (m) | (m) |
| 2021-06-30 | 16.87M | (m) | (m) |
| 2021-03-31 | 16.79M | (m) | (m) |
| 2020-09-30 | 12.43M | (m) | (m) |
| 2020-06-30 | 12.43M | (m) | (m) |
| 2020-03-31 | 6.85M | (m) | (m) |
| 2019-12-31 | 6.85M | (m) | (m) |
| 2019-09-30 | 6.83M | (m) | (m) |
| 2019-06-30 | 4.85M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |